ASCO Remembers Breast Cancer Drug Development Pioneer Dr. José Baselga
24-03-2021 09:47
ASCO and the oncology community are deeply saddened by the passingof JoséBaselga, MD, PhD, FASCO, on March 21, 2021, at age 61. Dr. Baselga died ofCreutzfeldt-Jakob disease,a rare fatal neurodegenerative disorder, according to his family.READ MORE
Pembrolizumab + Lenvatinib Significantly Improved PFS & OS vs CT in Advanced Endometrial Cancer Following Prior Platinum-Based CT